Stacy Nelson serves as Vice President, Global Drug Development at Basking Biosciences, where she leads the strategic and operational direction of clinical development programs overseeing study design and execution. With deep experience across clinical operations, regulatory affairs, and business development, Stacy plays a critical role in advancing Basking’s lead program, BB-031, focused on acute ischemic stroke and other thrombotic conditions. Prior to joining Basking Biosciences, she has served in senior leadership roles at contract research organizations, biotechnology and pharmaceutical companies, bringing a proven track record of guiding therapies from early-stage research to market. Stacy holds a B.S. from the University of North Carolina at Chapel Hill.

LinkedIn